Ausgabe 2/2011
Inhalt (29 Artikel)
Accuracy of magnetic resonance in suspicious breast lesions: a systematic quantitative review and meta-analysis
Lidia Rosi Medeiros, Célia Scapin Duarte, Daniela Dornelles Rosa, Maria Isabel Edelweiss, Marcia Edelweiss, Fábio Rosa Silva, Erik Paul Winnnikow, Patrícia Duarte Simões Pires, Maria Inês Rosa
Dietary glycemic index, glycemic load, and risk of breast cancer: meta-analysis of prospective cohort studies
Jia-Yi Dong, Li-Qiang Qin
Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer
Susan F. Dent, Rania Gaspo, Michelle Kissner, Kathleen I. Pritchard
Overexpression of HER2 signaling to WAVE2–Arp2/3 complex activates MMP-independent migration in breast cancer
Mayumi Yokotsuka, Keiichi Iwaya, Tsuyoshi Saito, Atanasio Pandiella, Ryoji Tsuboi, Norio Kohno, Osamu Matsubara, Kiyoshi Mukai
Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas
Victoria Wargon, Sandra V. Fernandez, Mercedes Goin, Sebastián Giulianelli, Jose Russo, Claudia Lanari
Functional implication of TRAIL −716 C/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor
Ranjana Pal, Sailesh Gochhait, Shilpi Chattopadhyay, Pawan Gupta, Neeraj Prakash, Gaurav Agarwal, Arun Chaturvedi, Nuzhat Husain, Syed Akhtar Husain, Rameshwar N. K. Bamezai
Preclinical evaluation of nuclear morphometry and tissue topology for breast carcinoma detection and margin assessment
Ndeke Nyirenda, Daniel L. Farkas, V. Krishnan Ramanujan
The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells
Alejandro Vazquez-Martin, Cristina Oliveras-Ferraros, Sonia Del Barco, Begoña Martin-Castillo, Javier A. Menendez
RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies
Ke-Da Yu, Chen Yang, Lei Fan, Ao-Xiang Chen, Zhi-Ming Shao
Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors
Y. Amemiya, W. Yang, T. Benatar, S. Nofech-Mozes, A. Yee, H. Kahn, C. Holloway, Arun Seth
CD4+ T cells inhibit the neu-specific CD8+ T-cell exhaustion during the priming phase of immune responses against breast cancer
Maciej Kmieciak, Andrea Worschech, Hooman Nikizad, Madhu Gowda, Mehran Habibi, Amy Depcrynski, Ena Wang, Kamar Godder, Shawn E. Holt, Francesco M. Marincola, Masoud H. Manjili
Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers
Max Yan, Mukta Rayoo, Elena A. Takano, Stephen B. Fox
A gene expression signature identifies two prognostic subgroups of basal breast cancer
Renaud Sabatier, Pascal Finetti, Nathalie Cervera, Eric Lambaudie, Benjamin Esterni, Emilie Mamessier, Agnès Tallet, Christian Chabannon, Jean-Marc Extra, Jocelyne Jacquemier, Patrice Viens, Daniel Birnbaum, François Bertucci
Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen
Mahmoud R. Khoshnoud, Britta Löfdahl, Helena Fohlin, Tommy Fornander, Olle Stål, Lambert Skoog, Jonas Bergh, Bo Nordenskjöld
Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer
Rosalba Torrisi, Vincenzo Bagnardi, Nicole Rotmensz, Eloise Scarano, Monica Iorfida, Paolo Veronesi, Alberto Luini, Giuseppe Viale, Armando Santoro, Marco Colleoni, Aron Goldhirsch
Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancer
Norikazu Masuda, Hiraji Iwata, Yoshiaki Rai, Keisei Anan, Toru Takeuchi, Norio Kohno, Hiroyuki Takei, Yasuhiro Yanagita, Shinzaburo Noguchi
A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women
T. Cigler, H. Richardson, M. J. Yaffe, C. J. Fabian, D. Johnston, J. N. Ingle, E. Nassif, R. L. Brunner, M. E. Wood, J. L. Pater, H. Hu, S. Qi, D. Tu, P. E. Goss
Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial
Mogens Bernsdorf, Christian Ingvar, Leif Jörgensen, Malgorzata K. Tuxen, Erik H. Jakobsen, Anna Saetersdal, Marie Louise Kimper-Karl, Niels Kroman, Eva Balslev, Bent Ejlertsen
The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients
Soo Youn Bae, Se Kyung Lee, Min Young Koo, Sung Mo Hur, Min-Young Choi, Dong Hui Cho, Sangmin Kim, Jun-Ho Choe, Jeong Eon Lee, Jung-Han Kim, Jee Soo Kim, Seok Jin Nam, Jung-Hyun Yang
Effects on survival of menstrual cycle phase of adjuvant surgical oophorectomy in premenopausal women with breast cancer
Richard R. Love, Gregory S. Young, Erinn M. Hade, David Jarjoura
A non-synonymous polymorphism Thr115Met in the EpCAM gene is associated with an increased risk of breast cancer in Chinese population
Lan Jiang, Chun Zhang, Yinyan Li, Xiao Yu, Jian Zheng, Ping Zou, Yuting Li, Xiaonong Bin, Jiachun Lu, Yifeng Zhou
Fragment c gamma receptor gene polymorphisms and breast cancer risk in case–control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians
Motoki Iwasaki, Naoki Shimada, Yoshio Kasuga, Shiro Yokoyama, Hiroshi Onuma, Hideki Nishimura, Ritsu Kusama, Gerson S. Hamada, Ines N. Nishimoto, Hirofumi Iyeyasu, Juvenal Motola Jr., Fábio M. Laginha, Roberto Anzai, Shoichiro Tsugane
MMP9 polymorphisms and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study
Alicia Beeghly-Fadiel, Wei Lu, Xiao-Ou Shu, Jirong Long, Qiuyin Cai, Yongbin Xiang, Yu-Tang Gao, Wei Zheng
Human papillomavirus infection and sporadic breast carcinoma risk: a meta-analysis
Ni Li, Xiaofeng Bi, Yawei Zhang, Ping Zhao, Tongzhang Zheng, Min Dai
The CYP17A1 −34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers
Bella Kaufman, Yael Laitman, Elad Ziv, Ute Hamann, Diana Torres, Ephrat Levy Lahad, Rachel Beeri, Paul Renbaum, Anna Jakubowska, Jan Lubinski, Tomasz Huzarski, Aleksandra Tołoczko-Grabarek, Katarzyna Jaworska, Katarzyna Durda, Amanda B. Sprudle, Georgia Chenevix-Trench, Jacques Simard, Douglas F. Easton, Antoniou Antonis, Csilla Szabo, Eitan Friedman
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
Dawn L. Hershman, Theresa Shao, Lawrence H. Kushi, Donna Buono, Wei Yann Tsai, Louis Fehrenbacher, Marilyn Kwan, Scarlett Lin Gomez, Alfred I. Neugut
Mutation analysis of BRIP1 in male breast cancer cases: a population-based study in Central Italy
Valentina Silvestri, Piera Rizzolo, Mario Falchetti, Ines Zanna, Giovanna Masala, Simonetta Bianchi, Domenico Palli, Laura Ottini
PALB2 mutations in German and Russian patients with bilateral breast cancer
Natalia Bogdanova, Anna P. Sokolenko, Aglaya G. Iyevleva, Svetlana N. Abysheva, Magda Blaut, Michael Bremer, Hans Christiansen, Margret Rave-Fränk, Thilo Dörk, Evgeny N. Imyanitov
Is PCR testing of sentinel lymph nodes ready for clinical application in breast cancer?
Benjamin O. Anderson, Ira J. Bleiweiss